Polysialic acids: potential role in therapeutic constructs.
Gregoriadis
G
G
Centre for Drug Delivery Research, School of Pharmacy, University of London, UK.
Fernandes
A
A
McCormack
B
B
Mital
M
M
Zhang
X
X
D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D001709:Biotechnology; D002240:Carbohydrate Sequence; D002374:Catalase / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D004337:Drug Carriers / Q000008:administration & dosage* / Q000737:chemistry* / Q000493:pharmacokinetics; D016503:Drug Delivery Systems; D006801:Humans; D066298:In Vitro Techniques; D008657:Metabolic Clearance Rate; D008956:Models, Chemical; D008969:Molecular Sequence Data; D011134:Polysaccharides / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D012794:Sialic Acids / Q000008:administration & dosage* / Q000737:chemistry* / Q000493:pharmacokinetics
D004337:Drug Carriers; D011134:Polysaccharides; D012794:Sialic Acids; C021319:polysialic acid; C014420:colominic acid; D002374:Catalase; D001215:Asparaginase